Takahashi Keiko, Sumarriva Katherine, Kim Rachel, Jiang Rosie, Brantley-Sieders Dana M, Chen Jin, Mernaugh Raymond L, Takahashi Takamune
Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
PLoS One. 2016 May 5;11(5):e0154916. doi: 10.1371/journal.pone.0154916. eCollection 2016.
CD148 is a transmembrane protein tyrosine phosphatase that is expressed in multiple cell types, including vascular endothelial cells and duct epithelial cells. Previous studies have shown a prominent role of CD148 to reduce growth factor signals and suppress cell proliferation and transformation. Further, we have recently shown that thrombospondin-1 (TSP1) serves as a functionally important ligand for CD148. TSP1 has multiple structural elements and interacts with various cell surface receptors that exhibit differing effects. In order to create the CD148-specific TSP1 fragment, here we investigated the CD148-interacting region in TSP1 using a series of TSP1 fragments and biochemical and biological assays. Our results demonstrate that: 1) CD148 binds to the 1st type 1 repeat in TSP1; 2) Trimeric TSP1 fragments that contain the 1st type repeat inhibit cell proliferation in A431D cells that stably express wild-type CD148 (A431D/CD148wt cells), while they show no effects in A431D cells that lack CD148 or express a catalytically inactive form of CD148. The anti-proliferative effect of the TSP1 fragment in A431D/CD148wt cells was largely abolished by CD148 knockdown and antagonized by the 1st, but not the 2nd and 3rd, type 1 repeat fragment. Furthermore, the trimeric TSP1 fragments containing the 1st type repeat increased the catalytic activity of CD148 and reduced phospho-tyrosine contents of EGFR and ERK1/2, defined CD148 substrates. These effects were not observed in the TSP1 fragments that lack the 1st type 1 repeat. Last, we demonstrate that the trimeric TSP1 fragment containing the 1st type 1 repeat inhibits endothelial cell proliferation in culture and angiogenesis in vivo. These effects were largely abolished by CD148 knockdown or deficiency. Collectively, these findings indicate that the 1st type 1 repeat interacts with CD148, reducing growth factor signals and inhibiting epithelial or endothelial cell proliferation and angiogenesis.
CD148是一种跨膜蛋白酪氨酸磷酸酶,在多种细胞类型中表达,包括血管内皮细胞和导管上皮细胞。先前的研究表明,CD148在减少生长因子信号以及抑制细胞增殖和转化方面发挥着重要作用。此外,我们最近发现血小板反应蛋白-1(TSP1)是CD148功能上重要的配体。TSP1具有多个结构元件,并与表现出不同效应的各种细胞表面受体相互作用。为了构建CD148特异性的TSP1片段,我们在此使用一系列TSP1片段以及生化和生物学分析方法研究了TSP1中与CD148相互作用的区域。我们的结果表明:1)CD148与TSP1中的第1个1型重复序列结合;2)包含第1个1型重复序列的三聚体TSP1片段可抑制稳定表达野生型CD148的A431D细胞(A431D/CD148wt细胞)的增殖,而在缺乏CD148或表达催化失活形式CD148的A431D细胞中则无此作用。CD148敲低可在很大程度上消除TSP1片段对A431D/CD148wt细胞的抗增殖作用,并且第1个1型重复序列片段可拮抗该作用,而第2个和第3个1型重复序列片段则无此作用。此外,包含第1个1型重复序列的三聚体TSP1片段可增加CD148的催化活性,并降低表皮生长因子受体(EGFR)和细胞外信号调节激酶1/2(ERK1/2)(已确定的CD148底物)的磷酸化酪氨酸含量。在缺乏第1个1型重复序列的TSP1片段中未观察到这些效应。最后,我们证明包含第1个1型重复序列的三聚体TSP1片段可抑制培养的内皮细胞增殖以及体内血管生成。CD148敲低或缺失可在很大程度上消除这些效应。总的来说,这些发现表明第1个1型重复序列与CD148相互作用,减少生长因子信号并抑制上皮或内皮细胞增殖及血管生成。